WEST PHARMACEUTICAL SERVICES, INC. Recognition of Deferred Revenue
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Recognition of Deferred Revenue of $1.50 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-02-28.
Discontinued › Income Statement › Other Income
us-gaap:RecognitionOfDeferredRevenue · last filed 2017-02-28
- WEST PHARMACEUTICAL SERVICES, INC. recognition of deferred revenue for the quarter ending 2014-03-31 was $400.00K.
- WEST PHARMACEUTICAL SERVICES, INC. recognition of deferred revenue for the quarter ending 2013-12-31 was $300.00K.
- WEST PHARMACEUTICAL SERVICES, INC. recognition of deferred revenue for the quarter ending 2013-09-30 was $400.00K.
- WEST PHARMACEUTICAL SERVICES, INC. recognition of deferred revenue for the quarter ending 2013-06-30 was $300.00K.
- WEST PHARMACEUTICAL SERVICES, INC. recognition of deferred revenue for fiscal 2015 was $1.50M, a 0.00% change from fiscal 2014.
- WEST PHARMACEUTICAL SERVICES, INC. recognition of deferred revenue for fiscal 2014 was $1.50M, a 50.00% increase from fiscal 2013.
- WEST PHARMACEUTICAL SERVICES, INC. recognition of deferred revenue for fiscal 2013 was $1.00M.
| Period end | Recognition of Deferred Revenue 3 month | Recognition of Deferred Revenue 6 month | Recognition of Deferred Revenue 9 month | Recognition of Deferred Revenue 12 month |
|---|---|---|---|---|
| 2015-12-31 | $1.50M 10-K · filed 2017-02-28 | |||
| 2014-12-31 | $1.50M 10-K · filed 2017-02-28 | |||
| 2014-03-31 | $400.00K 10-Q · filed 2014-05-08 | $700.00K derived: sum of 2 quarters · filed 2016-02-26 | $1.10M derived: sum of 3 quarters · filed 2016-02-26 | $1.40M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $700.00K derived: sum of 2 quarters · filed 2016-02-26 | $1.00M derived: sum of 3 quarters · filed 2016-02-26 | $1.00M 10-K · filed 2016-02-26 |
| 2013-09-30 | $400.00K 10-Q · filed 2014-11-03 | $700.00K derived: sum of 2 quarters · filed 2014-11-03 | $700.00K 10-Q · filed 2014-11-03 | |
| 2013-06-30 | $300.00K 10-Q · filed 2014-08-01 | $300.00K 10-Q · filed 2014-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |